Zealand Pharma AS (ZLDPF)
115.06
-1.00
(-0.86%)
USD |
OTCM |
Nov 14, 09:32
Zealand Pharma Enterprise Value: 6.972B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.972B |
| November 12, 2024 | 7.263B |
| November 11, 2024 | 7.675B |
| November 08, 2024 | 7.372B |
| November 07, 2024 | 7.183B |
| November 06, 2024 | 7.626B |
| November 05, 2024 | 7.526B |
| November 04, 2024 | 7.497B |
| November 01, 2024 | 7.234B |
| October 31, 2024 | 6.898B |
| October 30, 2024 | 7.170B |
| October 29, 2024 | 7.170B |
| October 28, 2024 | 7.392B |
| October 25, 2024 | 7.392B |
| October 24, 2024 | 7.392B |
| October 23, 2024 | 7.220B |
| October 22, 2024 | 7.145B |
| October 21, 2024 | 7.011B |
| October 18, 2024 | 7.007B |
| October 17, 2024 | 6.850B |
| October 16, 2024 | 6.686B |
| October 15, 2024 | 6.852B |
| October 14, 2024 | 6.784B |
| October 11, 2024 | 6.852B |
| October 10, 2024 | 7.081B |
| Date | Value |
|---|---|
| October 09, 2024 | 6.898B |
| October 08, 2024 | 7.093B |
| October 07, 2024 | 6.903B |
| October 04, 2024 | 6.722B |
| October 03, 2024 | 6.943B |
| October 02, 2024 | 7.258B |
| October 01, 2024 | 7.463B |
| September 30, 2024 | 7.427B |
| September 27, 2024 | 7.448B |
| September 26, 2024 | 7.626B |
| September 25, 2024 | 8.122B |
| September 24, 2024 | 7.777B |
| September 23, 2024 | 7.787B |
| September 20, 2024 | 8.381B |
| September 19, 2024 | 8.222B |
| September 18, 2024 | 8.222B |
| September 17, 2024 | 8.314B |
| September 16, 2024 | 8.314B |
| September 13, 2024 | 8.460B |
| September 12, 2024 | 8.038B |
| September 11, 2024 | 8.120B |
| September 10, 2024 | 7.678B |
| September 09, 2024 | 7.624B |
| September 06, 2024 | 7.733B |
| September 05, 2024 | 7.559B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
412.20M
Minimum
May 11 2022
8.888B
Maximum
Jun 28 2024
2.297B
Average
1.278B
Median
Enterprise Value Benchmarks
| Novo Nordisk AS | 472.39B |
| Genmab AS | 11.17B |
| Ascendis Pharma AS | 7.975B |
| Galecto Inc | -10.60M |
| Evaxion Biotech AS | 5.018M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -39.26M |
| Revenue (Quarterly) | 0.6506M |
| Total Expenses (Quarterly) | 52.14M |
| EPS Diluted (Quarterly) | -0.5556 |
| Profit Margin (Quarterly) | -6.03K% |
| Earnings Yield | -2.12% |
| Normalized Earnings Yield | -1.924 |